Dry Eye Disease Diagnostics & Treatment Market – Global Industry Analysis, Technological Innovations, Trends, Growth Opportunities and Demand Forecast

SDKI Inc. published a new report on the dry eye disease diagnosis and treatment market. The study includes the statistical and analytical approaches needed to grow the dry eye disease diagnosis and treatment market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-111326

The dry eye disease diagnosis and treatment market is estimated to reach US $ 9.94 billion by 2031 from a market value of US $ 6.73 billion in 2022 and is expected to grow at a CAGR of 5% during the 2022-2031 forecast period.

Dry eye is tear film due to tear film deficiency or excessive evaporation. It is a membrane disorder. It damages the interocular surface and is accompanied by symptoms of eye discomfort. Various diagnostic tests are performed to diagnose dry eye, such as Schirmer's test, corneal staining, and tear osmolality. Treatment options for dry eye include artificial tears, anti-inflammatory drugs, and secretagogues. Diagnostic tests for dry eye generally include tests that measure three diagnostic factors, such as subjective symptoms, tear function, and vital stain tests. In addition, several diagnostic tests have been developed, including Schirmer's test, corneal staining, tear decay time (TBUT), tear osmolality, tear stability analysis, and OCT.

Increasing prevalence and incidence of dry eye disease, as well as the growing aging population, are key factors driving the growth of the global dry eye diagnosis and treatment market during the forecast period. According to an article published in the American Journal of Ophthalmology, the estimated prevalence of dry eye in the United States between 2003 and 2015 was 5.28%. Technological advances in diagnostic tools and promising pipeline products for treatment, adverse effects of rising pollution levels, and increased use of electronic devices are also contributing to the growth of the dry eye disease diagnosis and treatment market. In addition, the increasing number of laser in-situ keratomileusis (LASIK) surgery creates growth opportunities in the dry eye disease diagnosis and treatment market during the forecast period 2022-2031.

Global market growth can be attributed to various significant advances in the healthcare industry to promote health through the development of three basic parameters: detection, prevention, and treatment. These parameters are needed to measure health, quality of life, and the overall health system. In addition, rising medical costs are driving market growth. According to the Organization for Economic Co-operation and Development (OECD) statistics, Japan's total per capita health care costs (government, compulsory health insurance, voluntary health insurance) increased from US $ 4297.13 in 2016 to US $ 4823 in 2019. Similarly, in the United States, it increased from $ 9880.16 to $ 11072 in 2019. Germany has witnessed an increase from $ 5668 to $ 6646, and the United Kingdom has observed growth from $ 3990 to $ 4653.05 during the above period. Globally, healthcare costs are projected to grow at a CAGR of approximately 5% between 2020 and 2024.

Sample URL of the report
https://www.sdki.jp/sample-request-111326

Advances in the healthcare sector are estimated to provide lucrative business opportunities for key players to take advantage of these opportunities in the coming years. In addition, there are several initiatives taken by healthcare professionals and government agencies to overcome some challenges (unreachable and affordable medical services, lack of medical investment, trained doctors and nurses, etc.). It is expected to boost market growth during the forecast period.

Dry Eye Disease Diagnosis and Treatment Market Segment

Dry Eye Disease Diagnosis and Treatment Market is divided by type (diagnostic test and treatment), disease (evaporative dry eye syndrome and aqueous dry eye syndrome), and region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional Overview of the Dry Eye Diagnosis and Treatment Market

North American region will dominate the global dry eye diagnosis and treatment market in 2019, and this trend is projected to continue during the forecast period. This is due to the increased number of prescriptions for dry eye treatment and the preferred reimbursement scenario for diagnostic testing of dry eye disease. The high prevalence of dry eye disorders and the approval of branded products by key players also contribute to the growth of the dry eye disease diagnosis and treatment market in the region. Meanwhile, the Asia Pacific dry eye disease diagnosis and treatment market is expected to grow at a high CAGR during the forecast period. This is due to an increase in the prevalence and incidence of dry eye syndrome, an increase in the elderly population, and a surge in the number of ophthalmic medical centers.

These regional segments are North America (US and Canada); Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Singapore, Other Asia Pacific); Latin America (Brazil, Mexico, Argentina, etc.) Latin America); Middle East and Africa (Israel, GCC [Saudi Arabia, Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa) and Europe (UK, Germany, France, Italy) , Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe) and more.

A major key player in the dry eye disease diagnosis and treatment market

Major key players in the dry eye disease diagnosis and treatment market include Novartis AG, Allergan plc, OASIS Medical, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd., Sentis Pharma Pvt. Ltd. , Tomey Corporation, Carl Zeiss Meditec AG and more. The study includes a detailed competitive analysis of these leading companies in the dry eye disease diagnosis and treatment market, corporate profiles, recent developments, and key market strategies.

Details of the survey report
https://www.sdki.jp/press-details/dry-eye-disease-diagnosis-and-treatment-market/671

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.